Viruses affecting lentil (Lens culinaris Medik.) in Greece; incidence and genetic variability of Bean leafroll virus and Pea enation mosaic virus

In Greece, lentil (Lens culinaris Medik.) crops are mainly established with non-certified seeds of local landraces, implying high risks for seed transmitted diseases. During April and May of the 2007–2012 growing seasons, surveys were conducted in eight regions of Greece (Attiki, Evros, Fthiotida, Korinthos, Kozani, Larissa, Lefkada and Viotia) to monitor virus incidence in lentil fields. A total of 1216 lentil samples, from plants exhibiting symptoms suggestive of virus infection, were analyzed from 2007 to 2009, using tissue-blot immunoassays (TBIA). Pea seed-borne mosaic virus (PSbMV) overall incidence was 4.9%, followed by Alfalfa mosaic virus (AMV) (2.4%) and Bean yellow mosaic virus (BYMV) (1.0%). When 274 of the samples were tested for the presence of luteoviruses, 38.8% were infected with Bean leafroll virus (BLRV). Since BLRV was not identified in the majority of the samples collected from 2007 to 2009, representative symptomatic plants (360 samples) were collected in further surveys performed from 2010 to 2012 and tested by ELISA. Two viruses prevailed in those samples: BLRV (36.1%) was associated with stunting, yellowing, and reddening symptoms and Pea enation mosaic virus-1 (PEMV-1) (35.0%) was associated with mosaic and mottling symptoms. PSbMV (2.2%), AMV (2.2%), BYMV (3.9%) and CMV (2.8%) were also detected. When the molecular variability was analyzed for representative isolates, collected from the main Greek lentil production areas, five BLRV isolates showed 95% identity for the coat protein (CP) gene and 99% for the 3’ end region. Three Greek PEMV isolates co-clustered with an isolate from Germany when their CP sequence was compared with isolates with no mutation in the aphid transmission gene. Overall, limited genetic variability was detected among Greek isolates of BLRV and PEMV

Survey of Viruses Affecting Legume Crops in the Amhara and Oromia Regions of Ethiopia

Field surveys were undertaken to identify the viral diseases affecting lentil, faba bean, chickpea, pea, fenugreek and grass pea in two regions of Ethiopia. The surveys were conducted in the regions of Amhara (Gonder and Gojam administrative zones) and Oromia (Bale administrative zone) during the 2003/2004 and 2004/2005 growing seasons, respectively. The survey covered 138 randomly selected fields (48 faba bean, 10 pea, 38 grass pea, 34 chickpea, 8 lentil) in the Amhara region, and 51 legume fields (29 faba bean, 12 pea, 3 lentil, 5 fenugreek, 2 chickpea) in the Oromia region. Virus disease incidence was determined by laboratory testing of 100–200 randomly-collected samples from each field against the antisera of 12 legume viruses. Of the 189 fields surveyed, 121 and 7 had, at the time of the survey, a virus disease incidence of 1% or less and more than 6%, respectively, based on visual inspection in the field; later laboratory testing showed that the number of fields in these two categories was in fact 99 and 56, respectively. Serological tests indicated that the most important viruses in the Amhara region were Faba bean necrotic yellows virus (FBNYV), Bean yellow mosaic virus (BYMV), Pea seed-borne mosaic virus (PSbMV) and the luteoviruses [e.g. Beet western yellows virus (BWYV), Bean leaf roll virus (BLRV), Soybean dwarf virus (SbDV)]. By contrast, only FBNYV and the luteoviruses were detected in the Oromia region. Other viruses, such as Broad bean mottle virus (BBMV) and Alfalfa mosaic virus (AMV), were rarely detected in the Amhara region. This is the first report in Ethiopia of natural infection of faba bean, pea and fenugreek with SbDV, of fenugreek with BWYV, and of grass pea with BYMV, PSbMV and BWYV, and it is also the first recorded instance of BBMV infecting legume crops in Ethiopia

Climate change and pathways used by pests as challenges to plant health in agriculture and forestry.

Climate change already challenges people?s livelihood globally and it also affects plant health. Rising temperatures facilitate the introduction and establishment of unwanted organisms, including arthropods, pathogens, and weeds (hereafter collectively called pests). For example, a single, unusually warm winter under temperate climatic conditions may be sufficient to assist the establishment of invasive plant pests, which otherwise would not be able to establish. In addition, the increased market globalization and related transport of recent years, coupled with increased temperatures, has led to favorable conditions for pest movement, invasion, and establishment worldwide. Most published studies indicate that, in general, pest risk will increase in agricultural ecosystems under climate-change scenarios, especially in today?s cooler arctic, boreal, temperate, and subtropical regions. This is also mostly true for forestry. Some pests have already expanded their host range or distribution, at least in part due to changes in climate. Examples of these pests, selected according to their relevance in different geographical areas, are summarized here. The main pathways used by them, directly and/or indirectly, are also discussed. Understanding these path-ways can support decisions about mitigation and adaptation measures. The review concludes that preventive mitigation and adaptation measures, including biosecurity, are key to reducing the projected increases in pest risk in agriculture, horticulture, and forestry. Therefore, the sustainable management of pests is urgently needed. It requires holistic solutions, including effective phytosanitary regulations, globally coordinated diagnostic and surveillance systems, pest risk modeling and analysis, and preparedness for pro-active management

Trigger finger: etiology, evaluation, and treatment

Trigger finger is a common finger aliment, thought to be caused by inflammation and subsequent narrowing of the A1 pulley, which causes pain, clicking, catching, and loss of motion of the affected finger. Although it can occur in anyone, it is seen more frequently in the diabetic population and in women, typically in the fifth to sixth decade of life. The diagnosis is usually fairly straightforward, as most patients complain of clicking or locking of the finger, but other pathological processes such as fracture, tumor, or other traumatic soft tissue injuries must be excluded. Treatment modalities, including splinting, corticosteroid injection, or surgical release, are very effective and are tailored to the severity and duration of symptoms

Type I Interferon Drives Dendritic Cell Apoptosis via Multiple BH3-Only Proteins following Activation by PolyIC In Vivo

BACKGROUND: DC are activated by pathogen-associated molecular patterns (PAMPs), and this is pivotal for the induction of adaptive immune responses. Thereafter, the clearance of activated DC is crucial to prevent immune pathology. While PAMPs are of major interest for vaccine science due to their adjuvant potential, it is unclear whether and how PAMPs may affect DC viability. We aimed to elucidate the possible apoptotic mechanisms that control activated DC lifespan in response to PAMPs, particularly in vivo. METHODOLOGY/PRINCIPAL FINDINGS: We report that polyinosinic:polycytidylic acid (PolyIC, synthetic analogue of dsRNA) induces dramatic apoptosis of mouse splenic conventional DC (cDC) in vivo, predominantly affecting the CD8α subset, as shown by flow cytometry-based analysis of splenic DC subsets. Importantly, while Bim deficiency conferred only minor protection, cDC depletion was prevented in mice lacking Bim plus one of three other BH3-only proteins, either Puma, Noxa or Bid. Furthermore, we show that Type I Interferon (IFN) is necessary and sufficient for DC death both in vitro and in vivo, and that TLR3 and MAVS co-operate in IFNß production in vivo to induce DC death in response to PolyIC. CONCLUSIONS/SIGNIFICANCE: These results demonstrate for the first time in vivo that apoptosis restricts DC lifespan following activation by PolyIC, particularly affecting the CD8α cDC subset. Such DC apoptosis is mediated by the overlapping action of pro-apoptotic BH3-only proteins, including but not solely involving Bim, and is driven by Type I IFN. While Type I IFNs are important anti-viral factors, CD8α cDC are major cross-presenting cells and critical inducers of CTL. We discuss such paradoxical finding on DC death with PolyIC/Type I IFN. These results could contribute to understand immunosuppression associated with chronic infection, and to the optimization of DC-based therapies and the clinical use of PAMPs and Type I IFNs

Systematic evaluation of immune regulation and modulation

Cancer immunotherapies are showing promising clinical results in a variety of malignancies. Monitoring the immune as well as the tumor response following these therapies has led to significant advancements in the field. Moreover, the identification and assessment of both predictive and prognostic biomarkers has become a key component to advancing these therapies. Thus, it is critical to develop systematic approaches to monitor the immune response and to interpret the data obtained from these assays. In order to address these issues and make recommendations to the field, the Society for Immunotherapy of Cancer reconvened the Immune Biomarkers Task Force. As a part of this Task Force, Working Group 3 (WG3) consisting of multidisciplinary experts from industry, academia, and government focused on the systematic assessment of immune regulation and modulation. In this review, the tumor microenvironment, microbiome, bone marrow, and adoptively transferred T cells will be used as examples to discuss the type and timing of sample collection. In addition, potential types of measurements, assays, and analyses will be discussed for each sample. Specifically, these recommendations will focus on the unique collection and assay requirements for the analysis of various samples as well as the high-throughput assays to evaluate potential biomarkers

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two

Background The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd. Methods We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background. Results First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001). Conclusions In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival